By admin Final data from Phase III STS Trial Expected in Q3 2013
Company to Focus on Development of Sodium Thiosulfate (STS) for Prevention of Hearing Loss in Pediatric Oncology Patients
Possibility of Commercial Partnership for Eniluracil (EU) will be explored
Research Triangle Park, NC, August 09, 2013 – – Adherex Technologies Inc. (TSX:AHX, OTCQB: ADHXF), today reported […]